Penn AD

School of Nursing, University of California, San Francisco, San Francisco, CA, United States.

4 papers · ORCID

ArticlePsychedelics

Health-related behavioral changes following the use of psychedelics in naturalistic settings.

Teixeira PJ, Jain R, Penn AD +5

Europe PMC2025
ArticlePsilocybin

Psilocybin therapy for mood dysfunction in Parkinson's disease: an open-label pilot trial.

Bradley ER, Sakai K, Fernandes-Osterhold G +15

Europe PMC2025
ArticlePsilocybin

Single-Dose Psilocybin Treatment for Major Depressive Disorder: A Randomized Clinical Trial.

Raison CL, Sanacora G, Woolley J +31

Europe PMC2023
ArticlePsilocybin

Effects of Naturalistic Psychedelic Use on Depression, Anxiety, and Well-Being: Associations With Patterns of Use, Reported Harms, and Transformative Mental States.

Raison CL, Jain R, Penn AD +2

Europe PMC2022